Astrotech Corporation’s (NASDAQ: ASTC) board of directors and management announce that they have engaged Chardan to advise on strategic alternatives involving Astrotech subsidiary 1ST Detect Corporation, a manufacturer of advanced mass spectrometry technology used to detect and analyze trace levels of explosives, chemical warfare agents (CWAs), and volatile organic compounds (VOCs).
1ST Detect Corporation, a subsidiary of Astrotech Corporation (NASDAQ: ASTC), announced the United States Patent and Trademark Office (USPTO) issued a key patent for increasing the performance of the company’s unique ion trap mass spectrometer used for chemical analysis and detection. 1ST Detect’s total patent count is now 17 U.S. and 6 international issued, and 7 U.S. and 10 international pending.
Astrotech Corporation (NASDAQ: ASTC) subsidiary 1ST Detect Corporation and strategic partner Battelle Memorial Institute completed the Brassboard Phase and were awarded the Final Prototype Phase of the US military’s Next Generation Chemical Detector (NGCD) Multi-Sample Identifier (MSI) Technology Maturation and Risk Reduction Program.
1ST Detect Corporation was awarded three patents by the United States Patent Office (USPTO) enabling the field use of ion trap chemical analyzers in harsh and demanding environments.
1ST Detect Corporation, a subsidiary of Astrotech (NASDAQ:ASTC), has partnered with Smiths Detection Inc. – a subsidiary of Smiths Group (LSE: SMIN, ADR: SMGZY) to develop next generation explosives trace detection (ETD) systems for the Department of Homeland Security Science and Technology Directorate (DHS S&T) using 1ST Detect’s breakthrough chemical analyzer technology.